Pooled overall survival and safety data from the pivotal phase II studies (NP28673 and NP28761) of alectinib in ALK-positive non-small-cell lung cancer

Autor: Ou, Sai-Hong Ignatius, Gadgeel, Shirish M., Barlesi, Fabrice, Yang, James Chih-Hsin, De Petris, Luigi, Kim, Dong-Wan, Govindan, Ramaswamy, Dingemans, Anne-Marie, Crino, Lucio, Léna, Hervé, Popat, Sanjay, Ahn, Jin Seok, Dansin, Eric, Mitry, Emmanuel, Müller, Barbara, Bordogna, Walter, Balas, Bogdana, Morcos, Peter N., Shaw, Alice T. *
Zdroj: In Lung Cancer January 2020 139:22-27
Databáze: ScienceDirect
Externí odkaz: